rprml Antibody

What is RPRML and what is its biological significance?

RPRML (Reprimo-Like) is a protein related to Reprimo (RPRM), which functions as a downstream effector of p53-induced cell cycle arrest at the G2/M phase. The RPRM family is considered to include putative tumor suppressors that may be silenced in certain cancer types . RPRML is identified in UniProt as Q8N4K4 with Gene ID 388394 . Research indicates that RPRML expression patterns are tissue-specific and conserved across species, suggesting important biological functions . Understanding RPRML expression and regulation is particularly valuable for cancer research and cell cycle regulation studies.

What are the key characteristics of commercially available RPRML antibodies?

Commercial RPRML antibodies vary in their properties and applications. For example, polyclonal antibody ABIN7096553 is produced in rabbits using a synthesized peptide derived from human RPRML as the immunogen . This antibody:

• Detects endogenous levels of RPRML

• Shows reactivity with human and mouse samples

• Is suitable for ELISA applications (recommended dilution 1:20000-1:40000)

• Is supplied in phosphate buffered saline (pH 7.4) with 150 mM NaCl, 0.02% sodium azide, and 50% glycerol

• Requires storage at -20°C for stability up to 12 months

Other RPRML antibodies may target different epitopes. Some target the middle region (AA 41-90) and demonstrate cross-reactivity with multiple species including human, mouse, cow, guinea pig, rat, monkey, dog, and horse for Western blot applications .

What experimental applications are suitable for RPRML antibodies?

Based on available data, RPRML antibodies can be utilized in various experimental applications:

The selection of the appropriate application depends on the specific research question and available samples. For all applications, proper validation and controls are essential to ensure reliable results .

How should researchers validate RPRML antibodies before experimental use?

Proper antibody validation is crucial for generating reliable research data. For RPRML antibodies, a multi-step validation approach is recommended:

• Target specificity verification:

  • Use knockout/knockdown models as negative controls

  • Perform peptide competition assays using the immunizing peptide

  • Compare results with tissues known to express or lack RPRML

  • Use recombinant RPRML protein as a positive control

• Application-specific validation:

  • For Western blot: Verify correct molecular weight band

  • For immunohistochemistry: Confirm expected tissue localization pattern

  • For ELISA: Establish a standard curve with recombinant protein

• Cross-reactivity assessment:

  • Test against related proteins (especially RPRM)

  • Validate claimed cross-species reactivity with appropriate controls

According to comprehensive antibody characterization guidelines, validation should document that the antibody: (i) binds to the target protein; (ii) binds to the target protein in complex mixtures; (iii) does not bind to non-target proteins; (iv) performs as expected in the specific experimental conditions .

What protocol optimizations are critical for detecting RPRML in Western blot analyses?

Successful Western blot detection of RPRML requires careful optimization:

• Sample preparation:

  • Use appropriate lysis buffers containing protease inhibitors

  • Determine optimal protein loading (typically 20-50 μg total protein)

  • Ensure complete denaturation for SDS-PAGE

• Gel electrophoresis and transfer:

  • Select appropriate percentage gel (10-15% recommended for RPRML)

  • Optimize transfer conditions for proteins in RPRML's molecular weight range

  • Consider semi-dry vs. wet transfer based on protein properties

• Antibody incubation:

  • Test different blocking agents (BSA, non-fat milk)

  • Optimize primary antibody dilution through titration

  • Increase sensitivity with overnight incubation at 4°C

• Signal detection and analysis:

  • Choose appropriate detection method based on expected expression level

  • Include proper loading controls for quantification

  • Perform densitometric analysis with multiple biological replicates

This methodological approach is consistent with best practices for antibody use in protein detection applications .

How can researchers optimize RPRML expression analysis at the mRNA level?

For comprehensive analysis of RPRML expression, researchers often complement protein studies with mRNA analysis:

• RT-qPCR optimization:

  • Use validated primer pairs specific to RPRML

  • For example, zebrafish rprml primers:
    Forward: 5'-ACGAGCGCAAACTGTTCGTTAC-3'
    Reverse: 5'-TCATGAGGTTGCAGCCGAGAAA-3'

  • Include melt curve analysis to confirm amplicon specificity

  • Select appropriate reference genes (e.g., actb1 for developmental studies)

• Data analysis considerations:

  • Calculate relative expression using the ΔCT method against appropriate housekeeping genes

  • Present data as average relative expression ± SEM (for developmental studies) or as relative expression boxplots (for adult expression studies)

  • Use statistical programming tools (e.g., R package ggplot2) for data visualization

• Technical validation:

  • Run technical replicates for each biological sample

  • Include no-template controls and no-RT controls

  • Validate primer efficiency using standard curves

This multi-level approach ensures reliable quantification of RPRML expression at the transcriptional level.

What are common issues when working with RPRML antibodies and how can they be resolved?

Researchers commonly encounter several challenges when working with RPRML antibodies:

For polyclonal RPRML antibodies, background issues can be particularly challenging. Consider:

• Pre-adsorption against non-specific proteins

• Testing different secondary antibodies

• Using highly cross-adsorbed secondary antibodies to reduce cross-reactivity

How does antibody selection impact the reproducibility of RPRML research?

Antibody selection significantly impacts research reproducibility, with reports suggesting approximately 50% of commercial antibodies fail to meet basic characterization standards . For RPRML research:

• Documentation and reporting:

  • Always report complete antibody information (vendor, catalog number, lot, dilution)

  • Document all validation steps performed

  • Share negative results and validation challenges with the community

• Reproducibility considerations:

  • Use Research Resource Identifiers (RRIDs) to unambiguously identify antibodies

  • Consider recombinant antibodies when available for better consistency

  • Maintain detailed records of antibody performance across experiments

• Cross-laboratory validation:

  • Compare results with multiple antibodies targeting different epitopes

  • Collaborate with other labs to verify findings with independent reagents

  • Participate in antibody validation initiatives when possible

The reproducibility crisis in antibody research has led to estimated financial losses of $0.4-1.8 billion per year in the United States alone , highlighting the critical importance of proper antibody selection and validation for RPRML studies.

What are emerging techniques for improving RPRML detection specificity?

Several advanced approaches can enhance the specificity of RPRML detection:

• Recombinant antibody technology:

  • Sequence-defined antibodies provide consistent performance across batches

  • Initiatives like NeuroMab have demonstrated success in converting hybridoma-derived antibodies to recombinant formats with improved consistency

  • Consider using recombinant RPRML antibodies when available

• Multiplexed detection strategies:

  • Use multiple antibodies targeting different RPRML epitopes simultaneously

  • Combine antibody-based detection with nucleic acid analysis (e.g., RNA-Seq with proteomics)

  • Implement proximity ligation assays for enhanced specificity

• Advanced imaging techniques:

  • Super-resolution microscopy for improved subcellular localization

  • Spectral imaging to reduce autofluorescence interference

  • Automated image analysis for quantitative assessment

• Genetic tagging approaches:

  • CRISPR-mediated endogenous tagging of RPRML

  • Knock-in reporter systems for live cell imaging

  • Proximity-dependent labeling techniques (BioID, APEX)

These emerging methods can complement traditional antibody-based detection to provide more robust and specific information about RPRML expression and function.

How can RPRML antibodies be utilized in cancer research?

Given that RPRM family members function as putative tumor suppressors , RPRML antibodies have valuable applications in cancer research:

• Expression profiling across cancer types:

  • Compare RPRML levels between normal and malignant tissues

  • Correlate expression with clinical parameters and outcomes

  • Assess potential use as a diagnostic or prognostic biomarker

• Mechanism investigation:

  • Study RPRML subcellular localization in cancer cells

  • Analyze changes in expression following treatment with chemotherapeutic agents

  • Investigate protein-protein interactions using co-immunoprecipitation

• Functional studies:

  • Combine antibody detection with gain/loss-of-function experiments

  • Assess impact of RPRML modulation on cell cycle and apoptosis

  • Investigate relationship with p53 pathway components

• Translational applications:

  • Develop tissue microarray studies for patient stratification

  • Explore potential as a therapeutic target

  • Assess correlation with response to specific treatments

Similar to studies with Reprimo in pituitary tumors , RPRML antibodies can help elucidate the role of this protein in various cancer types.

What considerations are important when studying RPRML across different species?

RPRML expression patterns appear to be conserved across species , but cross-species studies require careful planning:

• Antibody cross-reactivity validation:

  • Empirically verify reactivity with each species of interest

  • Consider epitope conservation when selecting antibodies

  • Include appropriate positive controls from each species

• Developmental considerations:

  • Expression patterns may vary across developmental stages

  • Use stage-appropriate controls when comparing species

  • Consider evolutionary differences in tissue-specific expression

• Technical adaptations:

  • Optimize protocols for each species (fixation, antigen retrieval, etc.)

  • Use species-specific secondary antibodies

  • Adjust amplification methods based on expected expression levels

• Data interpretation:

  • Acknowledge species differences in protein function and regulation

  • Consider evolutionary conservation of signaling pathways

  • Validate findings across multiple model organisms when possible

Studies in zebrafish have established protocols for analyzing rprm gene family expression , which may be adapted for cross-species comparisons.

What future developments might improve RPRML antibody research?

Several emerging trends may enhance future RPRML antibody research:

• Standardized validation initiatives:

  • Participation in community-wide antibody validation efforts

  • Implementation of minimum reporting standards for antibody characterization

  • Development of shared repositories for validation data

• Technological advances:

  • Single-cell protein analysis techniques

  • Advanced multiplexing for simultaneous detection of multiple proteins

  • Integration of artificial intelligence for image analysis and quantification

• Enhanced accessibility:

  • Open-source antibody sequences enabling local production

  • Improved data sharing across research groups

  • Centralized databases of antibody performance metrics

• Systems biology integration:

  • Combined analysis of transcriptomics, proteomics, and functional data

  • Network analysis to position RPRML in broader signaling contexts

  • Computational prediction of protein interactions and functions

As antibody technology continues to evolve, large-scale initiatives like those focused on the human proteome will likely improve the quality and consistency of RPRML research tools .